This topic contains a solution. Click here to go to the answer

Author Question: A client is receiving an antibiotic with the potential for nephrotoxicity. Which item should the ... (Read 168 times)

vicky

  • Hero Member
  • *****
  • Posts: 586
A client is receiving an antibiotic with the potential for nephrotoxicity. Which item should the nurse should plan to monitor?
 
  1. Urinary concentration of the drug
  2. Route of drug administration
  3. Plasma levels of the drug
  4. Rate of intravenous administration

Question 2

The nurse is preparing to medicate a client for a migraine headache. The nurse should choose the drug with which half-life?
 
  1. 10 to 20 hours
  2. 5 to 10 days
  3. 2 to 3 hours
  4. 1 to 3 minutes



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Eunice618

  • Sr. Member
  • ****
  • Posts: 350
Answer to Question 1

Correct Answer: 3
Rationale 1: The urinary concentration of a drug will not provide an accurate measurement of nephrotoxicity.
Rationale 2: The route of administration will not determine nephrotoxicity.
Rationale 3: Plasma levels of a drug are an indicator of whether a drug is at a therapeutic or toxic level, and provide information as to whether a drug dosage needs adjustment.
Rationale 4: Although the rate at which a drug is administered intravenously can affect plasma levels and irritation to the vein, it would not provide the best measure of nephrotoxicity.
Global Rationale: Plasma levels of a drug are an indicator of whether a drug is at a therapeutic or toxic level, and provide information as to whether a drug dosage needs adjustment. The urinary concentration of a drug will not provide an accurate measurement of nephrotoxicity. The route of administration will not determine nephrotoxicity. Although the rate at which a drug is administered intravenously can affect plasma levels and irritation to the vein, it would not provide the best measure of nephrotoxicity.

Answer to Question 2

Correct Answer: 3
Rationale 1: A half-life of 10 to 20 hours is longer than would be needed to provide migraine pain relief.
Rationale 2: A half-life of 5 to 10 days is longer than would be needed to provide migraine pain relief.
Rationale 3: A drug with a half-life of 2 to 3 hours will be reduced by 50 in 2 to 3 hours, providing adequate time for the client to obtain pain relief.
Rationale 4: A drug with a half-life of 1 to 3 minutes would be eliminated in a very short time period and would not provide adequate pain relief.
Global Rationale: A drug with a half-life of 2 to 3 hours will be reduced by 50 in 2 to 3 hours, providing adequate time for the client to obtain pain relief. A half-life of 10 to 20 hours is longer than would be needed to provide migraine pain relief. A half-life of 5 to 10 days is longer than would be needed to provide migraine pain relief. A drug with a half-life of 1 to 3 minutes would be eliminated in a very short time period and would not provide adequate pain relief.




vicky

  • Member
  • Posts: 586
Reply 2 on: Jul 23, 2018
Excellent


bblaney

  • Member
  • Posts: 323
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

Of the estimated 2 million heroin users in the United States, 600,000–800,000 are considered hardcore addicts. Heroin addiction is considered to be one of the hardest addictions to recover from.

Did you know?

The senior population grows every year. Seniors older than 65 years of age now comprise more than 13% of the total population. However, women outlive men. In the 85-and-over age group, there are only 45 men to every 100 women.

Did you know?

As the western states of America were settled, pioneers often had to drink rancid water from ponds and other sources. This often resulted in chronic diarrhea, causing many cases of dehydration and death that could have been avoided if clean water had been available.

Did you know?

In the United States, there is a birth every 8 seconds, according to the U.S. Census Bureau's Population Clock.

Did you know?

The U.S. Preventive Services Task Force recommends that all women age 65 years of age or older should be screened with bone densitometry.

For a complete list of videos, visit our video library